Ravederm® (Ravederm® )

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceLead AcetateLead Acetate
Similar drugsTo uncover
  • Ravederm®
    ointment externally 
    BIOPIN PHARMA, LLC     Russia
    • Dosage form: & nbsp
    Ointment for external use.
    Composition:
    in 100 g of the ointment contains lead acetate trihydrate 0.1 g,
    Excipients:
    olive oil 80 grams,
    beeswax yellow wax 19.68 g,
    methylparahydroxybenzoate (nipagina) 0.2 g,
    propyl parahydroxybenzoate (nipazole) 0.02 g.
    Description:Ointment light yellow with a faint smell of beeswax.
    Pharmacotherapeutic group:Anti-inflammatory for topical use.
    ATX: & nbsp

    S.01.B   Anti-inflammatory drugs

    Pharmacodynamics:
    Ravederm® is a remedy for topical treatment of burn wounds. It has wound healing, burns, moderate analgesic, antibacterial and antifungal action. The use of Raveerm ® ointment prevents the formation of coagulative necrosis. Gradual rejection of necrotic tissues occurs against a background of moderate inflammation that does not go beyond the limits of the burn zone. The change of the dressing is painless, without destroying the islets of the epithelium and the granulation tissue. Prevents the formation of contractures. The best results are achieved by using the ointment on the first day after the burn.
    Pharmacokinetics:
    Lead in the use of Radementm® ointment in the recommended dosage does not accumulate in the body in dangerous amounts. The percentage of lead resorption does not exceed 0.5-1%.

    Indications:Complex treatment of burns of II, III and degrees, including brushes and area of ​​joints (prevention of dermatogenic contractures); at the stage of preparing a burn wound for skin plasty; after performing necrectomy.
    Contraindications:
    Individual intolerance to ointment components, acute and chronic intoxication with lead. Childhood.
    It is not recommended to apply for a burn III b degree and area more than 10% of the body surface.
    Pregnancy and lactation:
    Do not use during pregnancy and lactation.

    Dosing and Administration:
    Outwardly.
    The ointment is applied to a sterile napkin with a layer of about 2 mm and is applied to the affected area. The layer of ointment should exceed the circumference of the wound by at least 5 mm. Change dressing is carried out once a day or as the dressing is impregnated with wound contents.
    The daily dose of the drug Ravederm® depends on the size of the surface of the burn, but not more than 10 g.
    The course of treatment is until the wound surface is completely healed, but not more than 30 days.
    Side effects:Sometimes there may be burning and itching at the site of application, passing alone after a few hours. Allergic reactions.
    Overdose:No cases of an overdose of Ravederm® were reported.
    Interaction:Not described.
    Special instructions:

    Form release / dosage:
    Ointment for external use 0,1%.
    Packaging:For 30 g and 40 g in aluminum tubes or 30 g and 40 g in polymer cans. Each tube or jar is packaged in a cardboard box with instructions for use.
    Storage conditions:Store at a temperature of 12 to 15 ° C. Keep out of the reach of children.
    Shelf life:
    3 years.
    Do not use after the expiration date.
    Terms of leave from pharmacies:On prescription
    Registration number:LSR-008002/10
    Date of registration:12.08.2010
    The owner of the registration certificate:BIOPIN PHARMA, LLC BIOPIN PHARMA, LLC Russia
    Manufacturer: & nbsp
    Representation: & nbspBIOPIN PHARMA LLC BIOPIN PHARMA LLC Russia
    Information update date: & nbsp13.08.2015
    Illustrated instructions
      Instructions
      Up